Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapy

Background. Chemotherapy is not given routinely to patients with malignancies receiving chronic haemodialysis because evidence of a clear benefit is still lacking and severe side effects are feared. The aim of our retrospective study was to analyse the methods of dose adjustment and the clinical cou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2005-06, Vol.20 (6), p.1187-1191
Hauptverfasser:	Boesler, Benjamin, Czock, David, Keller, Frieder, Griesshammer, Martin, Seufferlein, Thomas, Karges, Wolfram, Rasche, Franz Maximilian
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antineoplastic Agents - administration & dosage Antineoplastic Agents - pharmacokinetics Biological and medical sciences Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis chemotherapy Comorbidity dose adjustment Emergency and intensive care: renal failure. Dialysis management Female haemodialysis Humans Intensive care medicine Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - therapy Male malignancies Medical sciences Multiple Myeloma - drug therapy Multiple Myeloma - mortality Neoplasms - drug therapy Neoplasms - epidemiology nephropharmacology pharmacokinetics Renal Dialysis Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!